European Journal of Organic Chemistry
10.1002/ejoc.201601444
FULL PAPER
1
-(2-((4-Bromobut-2-yn-1-yl)oxy)-4-fluorophenyl)ethanone
Reaction of 4-fluoro-2-hydroxyacetophenone (500 mg, 3.18 mmol) with
,4-dibromobut-2-yne in THF according to the general procedure A
afforded 352 mg (39%) of product 10, isolated asa white solid. mp 58.8-
(10).
6-Chloro-4-trimethylsilyloxy-3-vinylidenechromane (17). Reaction of
2-((4-bromobut-2-yn-1-yl)oxy)-5-chlorobenzaldehyde (4) (100 mg, 0.348
mmol) according to the general procedure B afforded 86 mg (0.32 mmol,
1
-1
92%) of product 17, isolated ascolorlessoil. IR (film) v (cm ): 2956, 1962,
-1
1
1
6
0.3 ºC. IR (film) v (cm ): 3019, 1664, 1584, 1419, 1221, 1010, 827. H
NMR (300 MHz, CDCl3) δ: 7.86 – 7.80 (m, 1H), 6.80 – 6.74 (m, 2H), 4.87
t, J = 2.0 Hz, 2H), 3.94 (t, J = 2.0 Hz, 2H), 2.62 (s, 3H). 13C NMR (75 MHz,
CDCl3, DEPT) δ: 197.6 (C), 164.2 (C), 158.3 (C), 132.7 (CH), 125.1 (C),
1479, 1226, 1037,838,723. H NMR (300 MHz, CDCl3) δ: 7.20 – 7.13(m,
2H), 6.80 (d, J = 8.7 Hz, 1H), 5.12 (s, 1H), 4.98 – 4.97 (m, 2H), 4.78 (dt, J
= 11.4, 2.8 Hz, 1H), 4.63 (dd, J = 11.4, 0.9 Hz, 1H), 0.24 (s, 9H). 13C NMR
(75 MHz, CDCl3, DEPT) δ: 204.5 (C), 152.7 (C), 129.3 (CH), 128.9 (CH),
126.0 (C), 125.4 (C), 118.4 (CH), 96.8 (C), 77.5 (CH2), 66.0 (CH), 64.5
(
1
08.5 (CH), 100.9 (CH), 83.5 (C), 80.0 (C), 56.7 (CH2), 31.8 (CH3), 13.2
+
+
(CH2). HRMS (QTof): calc. for C12H11BrFO2 [M+1] : 284.9926, 286. 9906;
(CH2), 0.3 (CH3). HRMS (Qtof): calc. for C14H18ClO2Si [M+1] : 281.0759;
found 284.9924,286.9900.
found 281.0703.
1
-(2-((4-Bromobut-2-yn-1-yl)oxy)-5-chlorophenyl)ethanone
Reaction of 5-chloro-2-hydroxyacetophenone (500 mg, 2.90 mmol) with
,4-dibromobut-2-yne in THF according to the general procedure A
afforded 410 mg (47%) of product 11, isolated asa white solid. mp 74.3-
(11).
6-Bromo-4-trimethylsilyloxy-3-vinylidenechromane (18). IR (film) v
(cm ):2956, 1962, 1476, 1224, 998, 843, 815, 613. 1H NMR (300 MHz,
CDCl3) δ: 7.33 – 7.27 (m, 2H), 6.74 (d, J = 8.7 Hz, 1H), 5.12 (s, 1H), 4.97
– 4.96 (m, 2H), 4.77 (dt, J = 11.4, 2.8 Hz, 1H), 4.62 (dd, J = 11.4, 0.9 Hz,
1H), 0.24 (s, 9H). 13C NMR (75 MHz, CDCl3, DEPT) δ: 204.5 (C), 153.2
(C), 132.1 (CH), 131.8 (CH), 126.7 (C), 118.8 (CH), 112.6 (C), 96.9 (C),
77.4 (CH2), 66.1 (CH), 64.5 (CH2), 0.2 (CH3). HRMS (Qtof): calc. for
-1
1
-1
1
7
9.6 ºC. IR (film) v (cm ): 2885, 2256, 1670, 1473, 1180, 902, 640. H
NMR (300 MHz, CDCl3) δ: 7.83 (d, J = 2.6 Hz, 1H), 7.55 (dd, J = 8.8, 2.6
Hz, 1H), 6.95 (d, J = 8.8 Hz, 1H), 4.85 (t, J = 2.0 Hz, 2H), 3.92 (t, J = 2.0
Hz, 2H), 2.61 (s, 3H). 13C NMR (75 MHz, CDCl3, DEPT) δ: 197.8 (C), 155.6
+
C14H18BrO2Si [M+1] :325.0254; found 325.0224.
(C), 135.8 (CH), 133.0 (CH), 130.5 (C), 115.1 (CH), 114.2 (C), 83.4 (C),
8
0.3 (C), 56.8 (CH2), 31.7 (CH3), 13.3 (CH2). HRMS (QTof): calc. for
6
-Bromo-3-vinylidenechroman-4-ol (18a). To a solution of 18 (65mg,
+
C12H11BrClO2 [M+1] : 300.9631, 302.9610; found300.9621, 302.9602.
0.20 mmol) in THF (1 mL), 0.6 mL of n-Bu NF (1 M in THF) were added.
4
The reaction mixture was stirred under reflux for 12 h. Then, the solvent
was removed under reduced pressure and the residue was dissolved in
Et2O, washed with brine, dried over MgSO4 and filtered. The solvent was
again removed. Compound 18a (43mg, 0.17 mmol, 85%) was obtained
after purification by flash chromatography SiO2 (hexane/Et2O 4:6). IR (film)
1
-(5-Bromo-2-((4-bromobut-2-yn-1-yl)oxy)phenyl)ethanone
Reaction of 5-bromo-2-hydroxyacetophenone (500 mg, 2.28 mmol) with
,4-dibromobut-2-yne in THF according to the general procedure A
afforded 347 mg (44%) of product 12, isolated asa white solid. mp 78.3-
(12).
1
-1
1
-1
1
8
1.2 ºC. IR (film) v (cm ): 3001, 2243, 1664, 1476, 1205, 1003, 806. H
v (cm ): 3358, 2921, 1961, 1478, 1001, 750. H NMR (300 MHz, CDCl3)
δ: 7.55 (d, J = 2.5 Hz, 1H), 7.32 (dd, J = 8.8, 2.5 Hz, 2H), 6.77 (d, J = 8.8
Hz, 1H), 5.21 (s, 1H), 5.07 (dd, J = 4.2, 2.0 Hz, 2H), 4.78 (dd, J = 11.8, 2.4
NMR (300 MHz, CDCl3) δ: 7.84 (d, J = 2.6 Hz, 1H), 7.56 (dd, J = 8.8, 2.6
Hz, 1H), 6.95 (d, J = 8.8 Hz, 1H), 4.86 (t, J = 2.0 Hz, 2H), 3.93 (t, J = 2.0
1
3
13
Hz, 2H), 2.62 (s, 3H). C NMR (75 MHz, CDCl3, DEPT) δ: 197.87 (C),
55.60 (C), 135.82 (CH), 133.05 (CH), 130.49 (C), 115.13 (CH), 114.26
C), 83.41 (C), 80.29 (C), 56.76 (CH2), 31.70 (CH3), 13.31 (CH2). HRMS
Hz, 1H), 4.68 – 4.63 (m, 1H). C NMR (75 MHz, CDCl3, DEPT) δ: 204.00
1
(
(C), 153.30 (C), 132.45 (CH), 131.53 (CH), 126.07 (C), 118.84 (CH),
113.03 (C), 97.33 (C), 78.88 (CH2), 64.91 (CH2), 64.85 (CH). HRMS
+
+
(QTof): calc. for C12H11Br2O2 [M+1] : 346.9105; found 346.9126.
(QTof): calc. for C12H11BrO2 [M+1] : 252.9859; found 252.9849.
General experimentalprocedure B for the Ti(III) mediated cyclization.
6-Bromo-8-methyl-3-vinylidenechroman-4-ol (19).
Reaction of
[
TiCp2Cl2] (0.2equiv.) and Mndust (8 equiv.) are placed in a Schlenkflask
compound 6 (173 mg, 0.5 mmol) according to the general procedure B
afforded 134 mg (0.475mmol, 95%) of product 19, isolated as a light
under an Ar atmosphere. Then, carefully deoxygenated,dry THF (20 mL)
isadded and thered suspension isstirred at room temperature until it turns
lime green (after about 15 min). Next, a mixture of Me3SiCl (4 equiv.) and
-1
brown-green oil. IR (film) v (cm ): 3230, 2922, 2005, 1731, 1646, 1251,
1
1193, 1097, 933, 843, 734, 591. H NMR (400 MHz, CDCl3) δ: 7.37 (d, J=
2
,4,6-collidine (7 equiv.) in THF is added. Finally, a solution of the
2.5 Hz, 1H), 7.20 (d, J= 2.2 Hz, 1H), 5.18 (br s, 1H), 5.05 (br s, 2H), 4.78
substrate (1 equiv.) in THF (2 mL) is added dropwise over a period of 15
min and the mixture stirred for another 6 h. The reaction isquenched with
(dt, J= 11.7, 2.5 Hz ,1H), 4.68 (dt, J= 11.7, 1.4 Hz, 1H), 2.17 (s, 3H).13
C
NMR (100 MHz, CDCl3) (DEPT) δ: 203.9 (C), 151.4 (C), 133.2(CH), 129.1
2
N HCl and the organic solvent removed invacuo. The residue isdiluted
(CH), 128.7 (C), 125.2 (C), 112.4 (C), 97.2 (C), 78.9(CH2), 65.1 (CH), 64.8
-
in Et2O, washed with brine, dried (anhydrous MgSO4) and the solvent
evaporated. Products were always purified by silica gel flash column
chromatography (hexane/Et2O mixtures).
(CH2), 15.8 (CH3). HRMS (QTOF ES-): calculated for C12H10BrO2 [M-H]:
264.9869, 266.9884; found:264.9868, 266.9876.
6
-Bromo-8-tert-butyl-3-vinylidenechroman-4-ol (20). Reaction of
3
-(tert-Butyl)-4-vinylidenetetrahydrofuran-3-ol (15). Reaction of
compound 7 (100 mg, 0.26 mmol) according to the general procedure B
afforded 68 mg (84%) of product 20,isolatedasa light brown-greenoil. IR
compound 2 (150 mg, 0.74 mmol) according to the general procedure B
afforded 80.9 mg (65%) of product 15, isolated as colorless oil. 1H NMR
-1
(film) v (cm ): 3166, 2954, 1974,1730, 1431, 1252,1214, 1157, 1001, 871,
1
(300 MHz, CDCl3) δ: 5.06 (ddd, J = 11.0, 4.6, 3.8 Hz, 1H), 4.94 (ddd, J =
846, 733, 645, 519. H NMR (400 MHz, CDCl3) δ: 7.41 (d, J= 2.5 Hz, 1H),
1
4
1.0, 4.7, 3.9 Hz, 1H), 4.58 (dt, J = 11.9, 3.8 Hz, 1H), 4.37 – 4.29 (m, 1H),
7.30 (d, J= 2.5 Hz, 1H), 5.18 (br s, 1H), 5.06 (br s, 2H), 4.73 (dt, J= 11.8,
2.6 Hz, 1H), 4.68(dt, J= 11.8, 1.8 Hz, 1H), 1.35(s, 9H). C NMR (100 MHz,
13
13
.01 (dd, J = 9.7, 0.4 Hz, 1H), 3.77 (d, J = 9.6 Hz, 1H), 1.06 (s, 9H).
C
NMR (75 MHz, CDCl3, DEPT) δ: 199.8 (C), 106.2 (C), 85.7 (C), 80.7(CH2),
CDCl3) (DEPT) δ: 203.6 (C), 152.2 (C), 140.7 (C), 129.8 (CH), 129.4 (CH),
7
7.0 (CH2), 70.2 (CH2), 25.3 (CH3). HRMS (QTOF ES+): calc. for C10H17O
126.8 (C), 113.2 (C), 97.7 (C), 79.3 (CH2), 65.2 (CH), 64.4 (CH2), 35.01
(C), 29.5 (CH3). HRMS (QTOF ES-): calculated for C15H16BrO2 [M-H]:
+
-
[
M+H] : 169,1229; found 169,1235.
3
07.0339, 309.0318; found:307.0344, 309.0325
3
-Vinylidenechroman-4-ol (16) Reaction of 2-((4-Bromobut-2-yn-1-
yl)oxy)benzaldehyde (3) (100 mg, 0.395 mmol) according to the general
procedure B afforded 63 mg(92%) of product 16, isolatedascolorlessoil.
Data corresponds to that quoted in theliterature.12
Tetrahydro-4-methyl-3-vinylidene-2H-pyran-4-ol (21). Reaction of
compound 8 (150 mg, 0.68 mmol) according to the general procedure B
afforded 90.3 mg (94%) of product 21, isolated as colorless oil. 1H NMR
(300 MHz, CDCl3) δ: 4.93 (d, J = 10.6 Hz, 1H), 4.88 (dd, J = 11.0, 2.1 Hz,
This article is protected by copyright. All rights reserved.